QTRX 财务： Quanterix Corp AI 分析

主页

股票

QTRX

财务数据

QTRX 财务

Quanterix Corp

$3.6

6.19%

$0.2

收盘价：Apr 15, 16:00:00 GMT-4

$3.6

盘后：Apr 15, 17:07:42 GMT-4

概述预测财报股息财务数据

关键数据

前收盘价

$3.39

开盘价

$3.44

当日区间

$3.44 - $3.7

52周范围

$3.23 - $8.77

交易量

1.1M

平均成交量

719.8K

股息收益率

每股收益（TTM）

-2.52

市值

$168.9M

什么是 QTRX？

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2017-12-07. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

QTRX 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
营收	138	138	137	122	105	110
营收同比增长 (YoY)	-18%	1%	12%	16%	-5%	28%
营收成本	73	73	54	48	58	48
毛利	64	64	83	74	46	61
销售、一般及管理费用	126	122	104	92	93	92
研发	35	35	31	26	25	28
营业费用	161	158	135	118	119	120
其他非经营性收入 (费用)	4	4	0	2	0	1
税前利润	-112	-112	-38	-27	-96	-57
所得税费用	-5	-5	0	0	0	0
净利润	-107	-107	-38	-28	-96	-57
净利润增长	118%	182%	36%	-71%	68%	84%
稀释后流通股数	46.82	42.63	38.36	37.59	37	36
股份同比变动 (YoY)	21%	11%	2%	2%	3%	22%
每股收益 (摊薄)	-2.28	-2.51	-1	-0.75	-2.61	-1.6
每股收益增长率	76%	150%	33%	-71%	63%	50%
自由现金流	-79	-79	-38	-22	-60	-61
每股自由现金流	--	--	--	--	--	--
毛利率	46.37%	46.37%	60.58%	60.65%	43.8%	55.45%
营业利润率	-69.56%	-67.39%	-37.95%	-36.06%	-68.57%	-52.72%
净利率	-77.53%	-77.53%	-27.73%	-22.95%	-91.42%	-51.81%
自由现金流利润率	-57.24%	-57.24%	-27.73%	-18.03%	-57.14%	-55.45%
EBITDA	-81	-78	-46	-38	-67	-54
EBITDA 利润率	-58.69%	-56.52%	-33.57%	-31.14%	-63.8%	-49.09%
EBITDA 中的折旧与摊销	15	15	6	6	5	4
EBIT	-96	-93	-52	-44	-72	-58
EBIT 利润率	-69.56%	-67.39%	-37.95%	-36.06%	-68.57%	-52.72%
有效税率	4.46%	4.46%	0%	0%	0%	0%

Follow-Up Questions

Quanterix Corp 的关键财务报表是什么？



根据最新的财务报表（Form-10K），Quanterix Corp 的总资产为 $418，净损失为 $-107

QTRX 的关键财务比率是什么？



Quanterix Corp 的流动比率是 3.39，净利 margin 为 -77.53，每股销售为 $3.23。

Quanterix Corp 的收入按细分市场或地理位置如何划分？



Quanterix Corp 最大收入来源是 Ultra-sensitive Digital Immunoassay Platform，在最近的收益报告中收入为 122,368,000。就地区而言， North America 是 Quanterix Corp 的主要市场，收入为 76,512,000。

Quanterix Corp 是否盈利？



不，根据最新的财务报表，Quanterix Corp 的净损失为 $-107

Quanterix Corp 有负债吗？



是的，Quanterix Corp 的负债为 123

Quanterix Corp 的流通股有多少？



Quanterix Corp 的总流通股为 46.74

Quanterix Corp (QTRX) 财务

QTRX 股价走势图